市場調查報告書
商品編碼
1483681
口腔癌快速檢測套組市場 - 全球規模、佔有率、趨勢分析、機會、預測報告,2019-2030Oral Cancer Rapid Test Kit Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Type; By End User; By Region |
全球口腔癌快速檢測套組市場規模將以年複合成長率6.03%擴大,2030年將達12億美元
由於對市場開拓的投資以及口腔癌診斷設備和套件的引進的日益重視,全球口腔癌快速檢測套組市場蓬勃發展。
領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計,2023年全球口腔癌快速檢測套組市場規模將達到 9.8776 億美元。 BlueWeave預測,在2024-2030年的預測期內,口腔癌快速檢測套組的全球市場規模將以6.03%的年複合成長率成長,到2030年將達到11.8423億美元。由於菸草和酒精消費量的增加,口腔癌的盛行率不斷增加,生物感測器技術等檢測套組的進步是全球口腔癌快速檢測套組市場的主要成長動力。此外,隨著人們對癌症篩檢的認知不斷提高,預計口腔癌快速檢測套組的全球市場將受到推動。
機會研究和發展計劃擴展
針對全球口腔癌發生率不斷上升的情況,各國政府、研究機構和私人公司大力投資研發工作,以準確診斷癌症。例如,根據《國際癌症雜誌》發表的一項研究,倫敦大學瑪麗女王學院的研究人員聲稱開發了有史以來第一個針對口腔癌的 PCR 檢測方法。在分析期間,此類市場開拓預計將為全球口腔癌快速檢測套組市場的主要企業提供利潤豐厚的成長機會。
地緣政治緊張局勢加劇對全球口腔癌快速檢測套組市場的影響
地緣政治緊張局勢的加劇阻礙了全球口腔癌快速檢測套組市場的成長。例如,烏克蘭的癌症負擔很高,每年約有16萬人新診斷出癌症。然而,俄羅斯入侵烏克蘭對醫療基礎設施造成重大破壞,導致醫療保健專業人員和癌症患者移民到鄰國。由於缺乏醫療服務,包括口腔癌在內的癌症診斷數量大幅下降。巴勒斯坦也出現了類似的情況,加薩唯一的癌症醫院因以色列軍事佔領而缺乏燃料而關閉。
全球口腔癌快速檢測套組市場
依細分市場分類的覆蓋範圍
口腔癌快速檢測套組的全球市場 - 依類型
依類型分類,全球口腔癌快速檢測套組市場分為 OncAlert 口腔癌 LAB、晶片實驗室和 Prevo-check。 OncAlert口腔癌LAB在全球口腔癌快速檢測套組市場中佔有最大佔有率,預計在預測期內將實現較高的年複合成長率。這種經濟實惠的測試易於使用,不需要對患者進行侵入性操作,並且提供的觀察易於醫生理解。所有成年人都可以從準確且負擔得起的檢測中受益,但高風險族群,例如目前或以前使用菸草製品、飲酒過量以及感染 HPV-16 的人,可能受益最多。
全球口腔癌快速檢測套組市場(依地區)
關於全球口腔癌快速檢測套組市場的詳細研究報告涵蓋了北美、歐洲、亞太地區(APAC)、拉丁美洲和中東非洲五個主要地區的眾多各國市場。由於癌症篩檢率高以及 Viome、雅培實驗室和Thermo Fisher世爾科技等主要企業的集中,北美在口腔癌快速檢測套組的全球市場中佔據主導地位。由於亞太地區和歐洲的口腔癌盛行率不斷上升,預計在預測期內這些地區的成長率將顯著增加。
競爭格局
全球口腔癌快速檢測套組市場的主要公司有 Viome Life Sciences、Vigilant Biosciences、Grail、Abbott Laboratories、F. Hoffmann-La Roche AG、Siemens Healthineers AG、Thermo Fisher Scientific Inc.、Quidel Corporation、Bio-Rad Laboratories, Inc.、Danaher Corporation、Henry Schein, Inc.、Becton、Dickinson and Company 和Quest Diagnostics Incorporated。
為了進一步增加市場佔有率,這些公司採取各種策略,例如併購、合作、合資、授權合約和新產品發布。
本報告的詳細分析提供了有關成長潛力、未來趨勢和全球口腔癌快速檢測套組市場的資訊。也關注推動市場總規模預測的因素。本報告承諾提供全球口腔癌快速檢測套組市場的最新技術趨勢以及行業見解,以幫助決策者做出明智的策略決策。此外,也分析了市場的成長動力、挑戰和競爭動態。
Global Oral Cancer Rapid Test Kit Market Size Expands at Significant CAGR of 6.03% to Touch Whopping USD 1.2 Billion by 2030
Global Oral Cancer Rapid Test Kit Market is flourishing because of the growing focus on investments in the development and adoption of diagnostic equipment and kits for oral cancer.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Oral Cancer Rapid Test Kit Market size at USD 987.76 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Oral Cancer Rapid Test Kit Market size to expand at a CAGR of 6.03% reaching a value of USD 1,184.23 million by 2030. The increased incidence of oral cancer as a result of rising tobacco and alcohol consumption and advancements in testing kits, such as those in biosensor technology, are key growth drivers for the Global Oral Cancer Rapid Test Kit Market. Moreover, it is projected that the Global Oral Cancer Rapid Test Kit Market will be driven by growing awareness that will result in more cancer screenings.
Opportunity: Expanding research and development programs
Governments, research institutions, and private companies are heavily investing in research and development activities to accurately diagnose cancer in response to the rising incidence of mouth cancer worldwide. For example, research published in the International Journal of Cancer claims that researchers at Queen Mary University of London have developed the first-ever PCR test for mouth cancer. Such developments are anticipated to present lucrative growth opportunities for the major players in the Global Oral Cancer Rapid Test Kit Market during the period in analysis.
Impact of Escalating Geopolitical Tensions on Global Oral Cancer Rapid Test Kit Market
The escalating geopolitical tensions disrupted the growth of the Global Oral Cancer Rapid Test Kit Market. For instance, Ukraine has a high cancer burden with approximately 160,000 newly diagnosed patients with cancer each year. However, Russia's invasion of Ukraine resulted in significant damage to medical infrastructure and the migration of both healthcare professionals and cancer patients to neighboring countries. The inaccessibility of medical services led to a significant decline in cancer diagnoses, including oral cancer. Palestine witnessed a similar situation as well when Israel's military occupation of the country resulted in the shutting down of Gaza's only cancer hospital due to a fuel shortage.
Global Oral Cancer Rapid Test Kit Market
Segmental Coverage
Global Oral Cancer Rapid Test Kit Market - By Type
Based on type, the Global Oral Cancer Rapid Test Kit Market is divided into OncAlert oral cancer LAB, lab on a chip, and Prevo-check. OncAlert Oral Cancer LAB holds the largest share in the Global Oral Cancer Rapid Test Kit Market and is anticipated to register a high CAGR during the forecast period as well. This affordable test is simple to use, does not require intrusive procedures from the patient, and gives physicians findings that are straightforward to understand. All adults can benefit from the precise, affordable tests, but high-risk groups-such as those who use tobacco products now or in the past, drink excessively, or have HPV-16-may benefit most.
Global Oral Cancer Rapid Test Kit Market - By Region
The in-depth research report on the Global Oral Cancer Rapid Test Kit Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Oral Cancer Rapid Test Kit Market owing to its high cancer screening rate and high concentration of leading industry players, including Viome, Abbott Laboratories, and Thermo Fisher Scientific Inc. Asia Pacific and Europe are anticipated to register significant growth rates during the forecast period as well owing to the increasing prevalence of oral cancer in these regions.
Competitive Landscape
Major players operating in the Global Oral Cancer Rapid Test Kit Market include Viome Life Sciences, Vigilant Biosciences, Grail, Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Quidel Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Henry Schein, Inc, Becton, Dickinson and Company, and Quest Diagnostics Incorporated.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Oral Cancer Rapid Test Kit Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Oral Cancer Rapid Test Kit Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
Tables